# Celanese Corp: Form 10-Q for the period ended Sep 30, 2017

- Company: [Celanese Corp](/companies/ce.md) (CIK 1306830)
- Form: 10-Q
- Filed: 2017-10-17
- Accepted by EDGAR: Oct 17, 2017, 16:15 ET
- Period: 2017-09-30
- Accession: 0001306830-17-000226
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1306830/000130683017000226/ce-10q093017.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1306830/000130683017000226/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2017-09-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Cost of revenue | 3 months, 2017-07-01 to 2017-09-30 | $1.18bn | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 9 months, 2017-01-01 to 2017-09-30 | $3.44bn | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months, 2017-07-01 to 2017-09-30 | $385.0m | us-gaap:GrossProfit |
| Gross profit | 9 months, 2017-01-01 to 2017-09-30 | $1.10bn | us-gaap:GrossProfit |
| Research and development | 3 months, 2017-07-01 to 2017-09-30 | $19.0m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months, 2017-01-01 to 2017-09-30 | $53.0m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months, 2017-07-01 to 2017-09-30 | $112.0m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months, 2017-01-01 to 2017-09-30 | $291.0m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months, 2017-07-01 to 2017-09-30 | $252.0m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months, 2017-01-01 to 2017-09-30 | $684.0m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months, 2017-07-01 to 2017-09-30 | $32.0m | us-gaap:InterestExpense |
| Interest expense | 9 months, 2017-01-01 to 2017-09-30 | $91.0m | us-gaap:InterestExpense |
| Income tax | 3 months, 2017-07-01 to 2017-09-30 | $57.0m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months, 2017-01-01 to 2017-09-30 | $153.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2017-07-01 to 2017-09-30 | $226.0m | us-gaap:NetIncomeLoss |
| Net income | 9 months, 2017-01-01 to 2017-09-30 | $640.0m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2017-07-01 to 2017-09-30 | $1.65 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months, 2017-01-01 to 2017-09-30 | $4.60 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2017-07-01 to 2017-09-30 | $1.65 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months, 2017-01-01 to 2017-09-30 | $4.62 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2017-07-01 to 2017-09-30 | 136,951,923 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months, 2017-01-01 to 2017-09-30 | 138,988,321 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months, 2017-01-01 to 2017-09-30 | $745.0m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months, 2017-01-01 to 2017-09-30 | $180.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 9 months, 2017-01-01 to 2017-09-30 | $178.0m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 9 months, 2017-01-01 to 2017-09-30 | $500.0m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2017-09-30 | $461.0m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2017-09-30 | $2.61bn | us-gaap:AssetsCurrent |
| Total assets | at 2017-09-30 | $9.06bn | us-gaap:Assets |
| Current liabilities | at 2017-09-30 | $1.55bn | us-gaap:LiabilitiesCurrent |
| Long-term debt | at 2017-09-30 | $2.95bn | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | at 2017-09-30 | $435.0m | us-gaap:DebtCurrent |
| Shareholders' equity | at 2017-09-30 | $2.71bn | us-gaap:StockholdersEquity |
| Shares outstanding | at 2017-10-10 | 135,636,382 shares | dei:EntityCommonStockSharesOutstanding |

## Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/1306830/000130683017000226/ce-10q093017.htm

Filed Oct 17, 2017.
Source: SEC EDGAR, the filing index for accession 0001306830-17-000226. Last ingested by Listed: Nov 13, 2026, 16:24 ET. No prices; not investment advice.
